Irreversible dual inhibitory mode: the novel Btk inhibitor PLS-123 demonstrates promising anti-tumor activity in human B-cell lymphoma.
about
Targeting Btk with ibrutinib inhibit gastric carcinoma cells growth.The Bruton's tyrosine kinase inhibitor ibrutinib exerts immunomodulatory effects through regulation of tumor-infiltrating macrophagesTreatment with the C-C chemokine receptor type 5 (CCR5)-inhibitor maraviroc suppresses growth and induces apoptosis of acute lymphoblastic leukemia cells.The mTOR kinase inhibitor everolimus synergistically enhances the anti-tumor effect of the Bruton's tyrosine kinase (BTK) inhibitor PLS-123 on Mantle cell lymphoma.
P2860
Irreversible dual inhibitory mode: the novel Btk inhibitor PLS-123 demonstrates promising anti-tumor activity in human B-cell lymphoma.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Irreversible dual inhibitory m ...... vity in human B-cell lymphoma.
@ast
Irreversible dual inhibitory m ...... vity in human B-cell lymphoma.
@en
type
label
Irreversible dual inhibitory m ...... vity in human B-cell lymphoma.
@ast
Irreversible dual inhibitory m ...... vity in human B-cell lymphoma.
@en
prefLabel
Irreversible dual inhibitory m ...... vity in human B-cell lymphoma.
@ast
Irreversible dual inhibitory m ...... vity in human B-cell lymphoma.
@en
P2093
P2860
P356
P1433
P1476
Irreversible dual inhibitory m ...... vity in human B-cell lymphoma.
@en
P2093
Lingyan Ping
Lixia Feng
Xiaohui Zheng
Yunfei Shi
Yuqin Song
P2860
P304
15122-15136
P356
10.18632/ONCOTARGET.3824
P407
P577
2015-06-01T00:00:00Z